Intech Investment Management LLC lifted its holdings in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 21.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 176,721 shares of the health services provider's stock after purchasing an additional 30,892 shares during the quarter. Intech Investment Management LLC owned 0.14% of Select Medical worth $2,951,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd grew its holdings in Select Medical by 61.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider's stock worth $45,000 after purchasing an additional 1,030 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Select Medical during the 1st quarter valued at $60,000. Advisors Asset Management Inc. boosted its position in shares of Select Medical by 168.2% during the 1st quarter. Advisors Asset Management Inc. now owns 6,301 shares of the health services provider's stock worth $105,000 after acquiring an additional 3,952 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Select Medical by 217.4% during the 1st quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock worth $109,000 after buying an additional 4,453 shares during the last quarter. Finally, Lazard Asset Management LLC lifted its stake in Select Medical by 47.8% in the 4th quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock valued at $130,000 after purchasing an additional 2,255 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.
Select Medical Stock Performance
Shares of SEM stock opened at $12.53 on Monday. The firm has a 50 day moving average of $13.41 and a 200-day moving average of $15.08. The company has a market cap of $1.55 billion, a price-to-earnings ratio of 11.82, a price-to-earnings-growth ratio of 0.51 and a beta of 1.25. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.92. Select Medical Holdings Corporation has a 52 week low of $11.65 and a 52 week high of $40.98.
Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.04. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The firm had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the prior year, the business earned $0.60 earnings per share. The business's quarterly revenue was up 4.5% compared to the same quarter last year. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. On average, equities analysts forecast that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.
Select Medical Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Wednesday, August 13th were issued a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend was Wednesday, August 13th. Select Medical's payout ratio is currently 23.58%.
Wall Street Analysts Forecast Growth
SEM has been the topic of a number of research reports. UBS Group reissued a "neutral" rating and set a $14.00 target price (down from $15.00) on shares of Select Medical in a report on Monday, August 4th. Bank of America cut their price target on shares of Select Medical from $18.00 to $15.00 and set a "buy" rating on the stock in a report on Wednesday, September 10th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $19.20.
Read Our Latest Analysis on SEM
About Select Medical
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.